Alzahrani Mohammed A, Alshamrani Ali S, Ahmasani Ibrahim M, Alahmari Fahad S, Asiri Ali H, Alshehri Abdullah M, Alsamghan Awad S, Awadalla Nabil J
Department of Internal Medicine, College of Medicine, King Khalid University.
Medical Student, College of Medicine, King Khalid University, Abha 61421, Kingdom of Saudi Arabia.
Medicine (Baltimore). 2020 Dec 18;99(51):e23711. doi: 10.1097/MD.0000000000023711.
Coronavirus disease 2019 (COVID-19 pandemic has affected the psychological health of people, causing a higher level of stress. Stress can exaggerate the symptoms of irritable bowel syndrome (IBS).To assess the effect of the COVID-19 pandemic stress on patients with IBS in Saudi Arabia.A descriptive cross-sectional approach was used, which targeted accessible subjects with IBS from different regions of Saudi Arabia. Data were collected from participants using a structured electronic questionnaire, which captured the participants' socio-demographic data, medical history, IBS clinical data, self-reported stress due to COVID-19, and its effect on IBS symptoms.A total of 1255 IBS patients completed the questionnaire. About 63.4% of them reported stress due to the pandemic. The most frequently reported causes of stress were fear of infection occurring in the family, followed by fear of self-infection (43.5%), and death due to COVID-19 infection (17.2%). Most of the stressed participants (56.6%) reported that stress usually exaggerated IBS symptoms. Almost 22% of them consulted a physician for stress aggravation of the symptoms, 18.1% used sedatives due to stress, 9.2% modified IBS medications due to the stress, and 75.5% of the participants reported impaired daily activities due to symptoms exacerbation. Coexisting chronic morbidities and inability to differentiate between COVID-19 gastrointestinal symptoms and IBS symptoms were significantly associated with COVID-19 related stress (P = .039 and .001, respectively).Two-thirds of IBS patients were stressed during the first few months of COVID-19 pandemic. Patients unable to differentiate between COVID-19 gastrointestinal tract symptoms and IBS symptoms, and patients suffering from chronic morbidities were more vulnerable. Pandemic stress exacerbated patients' symptoms and impacted their activities of daily life.
2019冠状病毒病(COVID-19)大流行影响了人们的心理健康,导致压力水平升高。压力会加重肠易激综合征(IBS)的症状。为评估COVID-19大流行压力对沙特阿拉伯IBS患者的影响。采用描述性横断面研究方法,目标是沙特阿拉伯不同地区可接触到的IBS患者。通过结构化电子问卷收集参与者的数据,该问卷收集了参与者的社会人口学数据、病史、IBS临床数据、因COVID-19自我报告的压力及其对IBS症状的影响。共有1255名IBS患者完成了问卷。其中约63.4%报告因大流行感到压力。最常报告的压力源是担心家人感染,其次是担心自我感染(43.5%)和因COVID-19感染死亡(17.2%)。大多数感到压力的参与者(56.6%)报告压力通常会加重IBS症状。其中近22%因症状加重咨询过医生,18.1%因压力使用过镇静剂,9.2%因压力调整过IBS药物,75.5%的参与者报告因症状加重日常活动受到影响。并存的慢性疾病以及无法区分COVID-19胃肠道症状和IBS症状与COVID-19相关压力显著相关(P分别为0.039和0.001)。在COVID-19大流行的头几个月,三分之二的IBS患者感到压力。无法区分COVID-19胃肠道症状和IBS症状的患者以及患有慢性疾病的患者更容易受到影响。大流行压力加重了患者的症状并影响了他们的日常生活活动。